Effectiveness and safety of bedaquiline-containing regimens for treatment on patients with refractory RR/MDR/XDR-tuberculosis: a retrospective cohort study in East China

被引：0

作者：

Shao-Jun Zhang

Yan Yang

Wen-Wen Sun

Zhong-Shun Zhang

He-Ping Xiao

Yu-Ping Li

Zhe-Min Zhang

Lin Fan

机构：

[1] Shanghai Pulmonary Hospital,Department of Tuberculosis

[2] Tongji University School of Medicine,Department of Pharmacy

[3] Shanghai Clinic and Research Center of Tuberculosis,undefined

[4] Shanghai Key Lab of Tuberculosis,undefined

[5] Shanghai Pulmonary Hospital,undefined

[6] Tongji University School of Medicine,undefined

[7] Shanghai Pulmonary Hospital,undefined

[8] Tongji University School of Medicine,undefined

来源：

BMC Infectious Diseases | / 22卷

关键词：

BDQ; Multidrug-resistant; Rifampicin-resistant; Refractory tuberculosis;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[21] Bedaquiline Resistance and Treatment Outcomes Among Patients With Tuberculosis Previously Exposed to Bedaquiline in India: A Multicentric Retrospective Cohort Study
Singla, Rupak
Khan, Samsuddin
Silsarma, Arunima
Chavan, Vijay
Mahajan, Raman
Mansoor, Homa
Devan, Ravindra Kumar
Singla, Neeta
Bhalla, Manpreet
Kumar, Gavish
Singh, Pramila
Iyer, Aparna
Morales, Mabel
Devkota, Satish Chandra
Dalal, Alpa
Spencer, Hannah
Isaakidis, Petros
CLINICAL INFECTIOUS DISEASES, 2025,
[22] Comparison of effectiveness and safety of imipenem/clavulanate- versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB
Tiberi, Simon
Sotgiu, Giovanni
D'Ambrosio, Lia
Centis, Rosella
Arbex, Marcos Abdo
Arrascue, Edith Alarcon
Alffenaar, Jan Willem
Caminero, Jose A.
Gaga, Mina
Gualano, Gina
Skrahina, Alena
Solovic, Ivan
Sulis, Giorgia
Tadolini, Marina
Alarcon Guizado, Valentina
De Lorenzo, Saverio
Roby Arias, Aurora Jazmin
Scardigli, Anna
Akkerman, Onno W.
Aleksa, Alena
Artsukevich, Janina
Auchynka, Vera
Bonini, Eduardo Henrique
Chong Marin, Felix Antonio
Collahuazo Lopez, Lorena
de Vries, Gerard
Dore, Simone
Kunst, Heinke
Matteelli, Alberto
Moschos, Charalampos
Palmieri, Fabrizio
Papavasileiou, Apostolos
Payen, Marie-Christine
Piana, Andrea
Spanevello, Antonio
Vargas Vasquez, Dante
Viggiani, Pietro
White, Veronica
Zumla, Alimuddin
Migliori, Giovanni Battista
EUROPEAN RESPIRATORY JOURNAL, 2016, 47 (06) : 1758 - 1766
[23] Safety and effectiveness of all-oral and injectable-containing, bedaquiline-based long treatment regimen for pre-XDR tuberculosis in Vietnam
Thi Mai Phuong Nguyen
Binh Hoa Nguyen
Thi Thanh Thuy Hoang
Hoang Anh Nguyen
Dinh Hoa Vu
Mai Hoa Nguyen
Bao Ngoc Nguyen
Decroo, Tom
Viet Nhung Nguyen
FRONTIERS IN PHARMACOLOGY, 2022, 13
[24] Early safety and efficacy of the combination of bedaquiline and delamanid for the treatment of patients with drug-resistant tuberculosis in Armenia, India, and South Africa: a retrospective cohort study
Ferlazzo, Gabriella
Mohr, Erika
Laxmeshwar, Chinmay
Hewison, Catherine
Hughes, Jennifer
Jonckheere, Sylvie
Khachatryan, Naira
De Avezedo, Virginia
Egazaryan, Lusine
Shroufi, Amir
Kalon, Stobdan
Cox, Helen
Furin, Jennifer
Isaakidis, Petros
LANCET INFECTIOUS DISEASES, 2018, 18 (05): : 536 - 544
[25] Bedaquiline containing regimens for the treatment of multi- and extensively drug-resistant tuberculosis at the programmatic level in Belarus. Prospective cohort study
Skrahina, Alena
Hurevich, Henadz
Setkina, Sviatlana
Grankov, Viatcheslav
Solodovnikova, Varvara
Viatushka, Dzmitri
Kralko, Victoria
Klimuk, Dzmitry
Dara, Masoud
EUROPEAN RESPIRATORY JOURNAL, 2019, 54
[26] Bedaquiline Resistance and Treatment Outcomes Among Patients With Tuberculosis Previously Exposed to Bedaquiline in India: A Multicentric Retrospective Cohort Study (MAR, ciaf068, 2025)
Singla, Rupak
Khan, Samsuddin
Silsarma, Arunima
Chavan, Vijay
Mahajan, Raman
Mansoor, Homa
Devan, Ravindra Kumar
Singla, Neeta
Bhalla, Manpreet
Kumar, Gavish
Singh, Pramila
Iyer, Aparna
Morales, Mabel
Devkota, Satish Chandra
Dalal, Alpa
Spencer, Hannah
Isaakidis, Petros
CLINICAL INFECTIOUS DISEASES, 2025,
[27] The Safety and Efficacy of Prolonged Use of Bedaquiline for the Treatment of Patients with Pulmonary Multi-Drug Resistant/Rifampin-Resistant Tuberculosis: A Prospective, Cohort Study in China
Ke, Hui
Gui, Xuwei
Sun, Wenwen
Zhang, Shaojun
Yang, Yan
Zhang, Zhemin
Fan, Lin
INFECTION AND DRUG RESISTANCE, 2023, 16 : 5055 - 5064
[28] Bedaquiline safety, efficacy, utilization and emergence of resistance following treatment of multidrug-resistant tuberculosis patients in South Africa: a retrospective cohort analysis
Helen Pai
Norbert Ndjeka
Lawrence Mbuagbaw
Koné Kaniga
Eileen Birmingham
Gary Mao
Lori Alquier
Kourtney Davis
Arianne Bodard
Abeda Williams
Magalie Van Tongel
Florence Thoret-Bauchet
Shaheed V. Omar
Nyasha Bakare
BMC Infectious Diseases, 22
[29] Bedaquiline safety, efficacy, utilization and emergence of resistance following treatment of multidrug-resistant tuberculosis patients in South Africa: a retrospective cohort analysis
Pai, Helen
Ndjeka, Norbert
Mbuagbaw, Lawrence
Kaniga, Kone
Birmingham, Eileen
Mao, Gary
Alquier, Lori
Davis, Kourtney
Bodard, Arianne
Williams, Abeda
Van Tongel, Magalie
Thoret-Bauchet, Florence
Omar, Shaheed, V
Bakare, Nyasha
BMC INFECTIOUS DISEASES, 2022, 22 (01)
[30] Effectiveness of different treatment regimens on patients with COVID-19, hospitalized in Sanandaj hospitals: a retrospective cohort study
Asadi, Jalal
Rasouli, Mohammad Aziz
Ghaderi, Ebrahim
Roshani, Daem
Mohsenpour, Behzad
Moradi, Yousef
Moradi, Ghobad
JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2023, 16 (01)

← 1 2 3 4 5 →